•
Sep 30, 2012

Emergent BioSolutions Q3 2012 Earnings Report

Total Revenue
$66.6M
Previous year: $58.8M
+13.3%
EPS
$0.18
Previous year: $0.04
+350.0%
Gross Profit
$56.4M
Previous year: $48.1M
+17.3%
Cash and Equivalents
$198M
Previous year: $125M
+57.9%
Free Cash Flow
$36.9M
Previous year: -$12.5M
-394.5%
Total Assets
$540M
Previous year: $513M
+5.3%

Emergent BioSolutions

Emergent BioSolutions